Besides, some studies analyzed the value of combined utilization of the platelet APP ratio and APP secretase (ADAM10、BACE1 and PSEN-1) in AD, and found that the combination has a sensitivity of 88.9%, providing its potential application value in AD diagnosis and screening [27]. Here, ADAM10 is linked to Alzheimer disease.